Clinical Trial

Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma

Name: Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma — clinical trial record (NCT07730515)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

In this study, the XNW5004 tablets combined with CHOP/CHOEP will be used for the treatment of newly diagnosed PTCL patients.

Trial Details

NCT Number	NCT07730515
Lead Sponsor	Evopoint Biosciences Inc.
Conditions	Non-hodgkin Lymphoma, Peripheral T-cell Lymphoma
Enrollment	176 participants
Start Date	2025-08-15
Primary Completion	2028-09-30 (estimated)
Study Completion	2028-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-29